Expand SPRB Menu
SPRB MENU

SPRB Latest Press Releases

-- August 3, 2026 --

Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development Business Wire 8:00 AM

-- July 27, 2026 --

Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer Business Wire 8:00 AM

-- July 8, 2026 --

Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit Business Wire 4:01 PM

-- June 29, 2026 --

Spruce Biosciences Joins the Russell 3000 Index Business Wire 8:00 AM

-- June 22, 2026 --

Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs Business Wire 8:00 AM

-- June 15, 2026 --

Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller Business Wire 8:00 AM

-- June 8, 2026 --

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium Business Wire 4:05 PM

-- May 28, 2026 --

Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium Business Wire 4:05 PM

-- May 27, 2026 --

Spruce Biosciences to Participate in Upcoming Conferences in June Business Wire 4:05 PM

-- May 13, 2026 --

Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates Business Wire 8:00 AM

-- May 4, 2026 --

Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations Business Wire 8:00 AM

-- April 20, 2026 --

Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Business Wire 11:45 PM
Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Business Wire 4:01 PM

-- March 9, 2026 --

Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates Business Wire 7:05 AM
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer Business Wire 7:00 AM
Market Data Delayed 15 Minutes